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In-hospital and 3-year Clinical Outcomes Following Ad Hoc Versus Staged
Percutaneous Coronary Interventions in Chronic Total Occlusion-A Real World
Practice
Hsiu-Yu Fang
Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan
Background: Ad hoc percutaneous coronary intervention (PCI) which performed
immediately after diagnostic catheterization has become the most common way of
coronary intervention. However, limited data is available on in-hospital and long-term
outcome comparing ad hoc and staged chronic total occlusion (CTO) PCI. Our aim of
the study was to ﬁgure the short-term and long-term outcome after ad hoc or staged
CTO PCI.
Methods: This retrospective analysis included consecutive 512 patients underwent
561 CTO PCI procedures between January 2002 and December 2009. Patient basic
demographics, lesion characteristics, interventional procedure, devices used and in-
hospital outcomes were compared between ad hoc and staged CTO PCI groups. 3-year
clinical outcomes included all-cause mortality, cardiac mortality, myocardial infarc-
tion (MI), the need for coronary artery bypass graft surgery (CABG), major adverse
cardiac events (MACE) and target vessel revascularization (TVR) were compared.
Time-to-event analyses were performed using Kaplan-Meier statistics.
Results: Four hundred and ﬁfty-one patients (80.4%) were enrolled in ad hoc CTO
PCI group. Final successful revascularization was higher in ad hoc CTO PCI group
compared with staged CTO PCI group (82.9 vs. 77.3%, p¼0.17) without statistical
signiﬁcance. There was no signiﬁcant difference between ad hoc CTO PCI and staged
CTO PCI groups in in-hospital outcomes such as all-cause mortality, cardiac death,
myocardial infarction, urgent bypass surgery, urgent PCI or complications. Patients
with ad hoc CTO PCI had lower rate of all-cause mortality (6.2% vs. 6.5%, p¼0.89),
the need for CABG (1.9% vs. 2.1%, p¼0.89) but higher rate of cardiac mortality
(1.7% vs. 0.0%, p¼0.21), MI (1.0% vs. 0.0%, p¼0.34), MACE (24.1% vs. 17.5%,
p¼0.19) and TVR (17.8% vs. 10.0%, p¼0.069) without statistical signiﬁcance in
3-year clinical outcomes.
Conclusion: 3-year clinical outcomes compared with ad hoc CTO PCI and staged
CTO PCI had insigniﬁcant differences between: all-cause mortality, cardiac mortality,
MI, the need for CABG, MACE and TVR.Congenital Heart Disease
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Long-term Clinical Outcomes After Transcatheter Closure of Atrial Septal
Defect in Adult: Inﬂuence of Age Procedure
Yoichi Takaya, Teiji Akagi, Yasufumi Kijima, Koji Nakagawa, Shunji Sano,
Hiroshi Ito
Okayama University Graduate School of Medicine, Okayama, Japan
Background: Long-term clinical outcome after transcatheter closure of atrial septal
defect (ASD) in adults remains unknown, especially in geriatric population. The aim
of this study was to clarify the clinical implication of transcatheter closure of ASD
among the different patient population over than 55 years of age.
Methods: A total of 212 patients over than 55 years of age who underwent transcatheter
closure of ASD were enrolled. Patients were divided into 3 groups according to age at
the procedure (55-64 years: n¼ 89, 65-74 years: n¼ 72,75 years: n¼ 51). Cardiac or
non-cardiac events and the changes of NewYork Heart Association functional class and
hemodynamic parameters after the procedure were reviewed in each group.
Results: As shown in ﬁgure, Kaplan-Meier analysis revealed that the age at the proce-
dure did not inﬂuence on all-cause mortality (log-rank test, P ¼ 0.385) and cardiovas-
cular mortality (log-rank test, P¼ 0.938). Additionally, major events including all-cause
mortality and hospitalization due to heart failure or stroke were not different among the
3 different age groups at least 5 years follow-up period (log-rank test, P¼ 0.208). Even
in patients aged 75 years, the improvements in New York Heart Association
functional class (2.1 0.7 to 1.5 0.6, P<0.001) and right ventricular / left ventricular
end-diastolic diameter ratio (0.99  0.23 to 0.75  0.13, P <0.001) were observed
after the procedure, similar to the improvements in other 2 younger aged groups.
Conclusion: Although further long-term clinical outcomes are still unknown, our
ﬁndings demonstrated that the clinical implication of this procedure is reliable even in
geriatric population.S16 JACC Vol 63/12/Suppl S j ATCTAP A-055
Transcatheter Closure of Multiple Atrial Septal Defects with Two Amplatzer
Septal Occluder Devices
Hong Zheng
Fuwai Cardiovascular Hospital, Beijing, China
Background: In recent years, ASD(atrial septal defect, ASD) occlusion has been
widely promoted in China and also has achieved a great progress. However, it is
sometimes a tough job in the treatment of MASD(multiple atrial septal defects,pril 22–25, 2014 j TCTAP Abstracts/ORAL/Congenital Heart Disease
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involves more clinical experience and high incidence of complication. Since 1998, 17
patients with MASD have been treated with two occluders in our hospital, this article
is to evaluate the clinical feasibility and effectiveness of transcatheter closure of
MASD using two occluders.
Methods: 17 patients underwent transcatheter closure of MASD(2 or 3) with two
devices under X-ray ﬂuoroscopy and TTE. Electrocardiogram, X-ray chest radiog-
raphy as well as echocardiography were performed to evaluate the effectiveness after
the procedure.
Results: All patients had MASD (12 with 2 defects and 5 with 3 defects). TTE during
the procedures showed that the mean diameters of the larger, medium and smaller
defects was (13.943.21)mm, (9.652.64)mm and (4.801.92)mm, respectively.
Transcatheter closure of MASD succeeded in 16 patients (16/17,94.12%),1 failed
because the second defect was not suitable for intervention, and was cured by surgery.
Totally 32 occluder devices were implanted with 37 defects closed. The mean di-
ameters of the larger and the smaller occluders was (20.754.07)mm and
(16.943.75)mm, respectively, larger than the value showed by TTE during pro-
cedures by (7.062.65)mm (larger defects) and (7.443.25)mm (medium defects).
Immediately after the procedure, 3 patients had trivial shunt (2 patients with 3 defects),
which disappeared 2days, 3 days and 3 month later, respectively. No severe
complication occurred, while femoral arteriovenous ﬁstula was observed in 1 patient
and disappeared 1 month later. The cardiothoracic ratio of X-ray chest radiography
and the right ventricle internal diameter measured by echocardiography dropped
during follow-up (all P<0.01).
Conclusion: Transcatheter closure of MASD with two devices is feasible, safe and
effective.
TCTAP A-056
Beneﬁts of Percutaneous Atrial Septal Defect Occlusion in Patients Older than 60
Yam Hong Wong
Tuen Mun Hospital, Hong Kong, Hong Kong, China
Background: Excellent beneﬁts of percutaneous transcatheter secundum atrial septal
defect (ASD) occlusion at young age have been well demonstrated. Evidence
demonstrating that in elderly patient is not well established. In fact, early investigators
demonstrated less favourable results when closure is delayed until late adulthood. A
few recent studies, including the one published by Humenberer M et al in 2011,
supported that beneﬁts are still present after ASD occlusion in elderlies, but possibly
to a smaller magnitude. Most of these evidence supporting closure of ASD in older
population are relatively small-scale, or single-centered studies. Post-operative new
onset atrial arrhythmias were also shown to be more common in geriatric population.
Furthermore, latest evidence suggested an increased incidence of post-operative heart
failure, due to diastolic dysfunction in this age group.
It is crucial, to conﬁrm the signiﬁcance and magnitude of beneﬁts, and also the
safety proﬁle of ASD repair in geriatric patients, in order to justify this treatment.
Methods: With an “all-comers” design, all adult patients with percutaneous ASD
occlusions ever performed in the involved tertiary cardiac centers in Hong Kong were
recruited. They were divided into the younger (< 60 years) and older ( 60 years) age
groups. Pre-operative and earliest post-operative measurements of pulmonary arterial
systolic pressure (PASP), and right ventricular internal diastolic diameter (RVID) were
assessed as primary endpoints. Subjective symptoms, incidence of new onset atrial
arrhythmia, thromboembolism, and bleeding complications were recorded as second-
ary endpoints. These results in the two age groups were then compared with each other.
Results: 54 younger and 19 older patients were evaluated. Highly signiﬁcant im-
provements pulmonary hypertension in terms of PASP (from 42.09  11.37 mmHg to
31.93  9.71 mmHg in the younger; and from 52.40  17.01 mmHg to 36.81  12.11
mmHg in the older age group) (Figure 1 and 2), and right ventricle (RV) dilation in
terms of RVID (from 3.54  0.86 cm to 2.67  0.66 cm in the younger; and from
3.85  0.68 cm to 3.02  0.71 cm in the older age group) (Figure 3 and 4) were noted
in both groups of patients.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/ORAAbsolute changes in PASP and RVID did not signiﬁcantly differ amongst age
groups (Figure 5 and 6).All secondary endpoints, including safety outcomes, are also statistically similar
between the older and the young age groups. Complications are rare. And majority of
symptomatic patients in both groups experienced symptom improvements after the
procedure (Figure 7).L/Congenital Heart Disease S17
